Author:
Giamarellos-Bourboulis E. J.,Mouktaroudi M.,Netea M. G.
Publisher
Springer International Publishing
Reference31 articles.
1. Rhodes A, Evans LE, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2016. Crit Care Med. 2017;45:486–552.
2. Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34:1589–96.
3. Karakike E, Giamarellos-Bourboulis EJ, Kyprianou M, et al. Coronavirus disease 2019 as cause of viral sepsis: a systemic review and meta-analysis. Crit Care Med. 2021;49:2042–57.
4. Paranjape N, Husain M, Preistley J, Koonjah Y, Watts C, Havlik J. Early use of remdesivir in patients hospitalized with COVID-19 improves clinical outcomes: a retrospective observational study. Infect Dis Clin Pract. 2021;29:e282–6.
5. Laguna-Goyal R, Utrero-Rico A, Talayero P, et al. IL-6-based mortality risk model for hospitalized patients with COVID-19. J Allergy Clin Immunol. 2020;146:799–807.